Provided by Tiger Fintech (Singapore) Pte. Ltd.

Athira Pharma, Inc.

0.3095
-0.0117-3.64%
Volume:251.68K
Turnover:80.01K
Market Cap:12.08M
PE:-0.15
High:0.3400
Open:0.3200
Low:0.3050
Close:0.3212
Loading ...

Athena Gold Grants Stock Options to Key Personnel

TIPRANKS
·
10 hours ago

Athira Pharma Inc. Conducted Annual Stockholders Meeting

Reuters
·
03 Jun

Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105

TIPRANKS
·
13 May

Athira Pharma Reports Reduced Losses and Strategic Focus

TIPRANKS
·
10 May

Athira Pharma Q1 EPS $(0.23) Up From $(0.69) YoY

Benzinga
·
10 May

BRIEF-Athira Pharma Q1 EPS USD -0.23

Reuters
·
10 May

Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates

THOMSON REUTERS
·
10 May

Athira Pharma Inc - to Explore Strategic Alternatives

THOMSON REUTERS
·
10 May

Athira Pharma Q1 EPS USD -0.23

THOMSON REUTERS
·
10 May

Athira Pharma Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
09 May

ATHA Energy Secures $10 Million for Uranium Exploration

TIPRANKS
·
22 Apr

Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained

TIPRANKS
·
03 Mar

Athira Pharma’s 2024 Financial Results and Pipeline Progress

TIPRANKS
·
01 Mar

Athira Pharma (ATHA) Gets a Hold from JMP Securities

TIPRANKS
·
28 Feb

Athira Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Athira Pharma FY 2024 GAAP EPS $(2.52) Beats $(2.54) Estimate

Benzinga
·
28 Feb

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates

GlobeNewswire
·
28 Feb

Athira Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
24 Feb

Athira Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
18 Feb

Terra Uranium unveils co-ordinated exploration strategy for Athabasca Basin

Small Caps
·
06 Feb